A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Fertility and Sterility

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.fertnstert.2010.05.047PMID 20630504PMCID PMC2989416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy

  2009cited by this paper
• TGF-β signaling in vascular biology and dysfunction

  2009cited by this paper
• Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries

  2009cited by this paper
• Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.

  2007cited by this paper
• Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.

  2007cited by this paper
• Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome.

  2006cited by this paper
• Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity

  2006cited by this paper
• Marfan's syndrome and related disorders--more tightly connected than we thought.

  2006cited by this paper
• Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest.

  2006cited by this paper
• Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

  2005cited by this paper
• Marfan's syndrome.

  2005cited by this paper
• Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2.

  2005cited by this paper
• Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.

  2005cited by this paper
• Activin and follistatin in female reproduction.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Fibrillin controls TGF-beta activation.

  2003cited by this paper
• Fibrillin controls TGF-β activation

  2003cited by this paper
• Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.

  2002cited by this paper
• Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.

  2002cited by this paper
• Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus.

  2001cited by this paper
• Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.

  2001cited by this paper
• Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

  2000cited by this paper
• Allelic variants of the follistatin gene in polycystic ovary syndrome.

  2000cited by this paper
• A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth.

  2000cited by this paper
• Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage

  2000cited by this paper
• Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

  1999cited by this paper
• Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

  1998cited by this paper
• The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

  1996cited by this paper
• Hirsutism: implications, etiology, and management.

  1981cited by this paper
• REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME

  1980cited by this paper

• Beyond glycemic control: molecular mechanisms of metformin in modulating cytokine networks in polycystic ovary syndrome.

  2026cites this paper
• TGF-β Signaling in the Pathophysiology of the Ovary: A Double-Edged Regulator

  2026cites this paper
• Exploring critical hub genes and potential drug candidates for PCOS: A systems biology approach.

  2025cites this paper
• Empagliflozin as a potential therapy for PCOS: Restoring hormonal balance and ovarian function in a letrozole-induced rat model.

  2025cites this paper
• Prevalence of anti-thyroid peroxidase antibodies among women with polycystic ovary syndrome

  2025cites this paper
• The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review

  2025cites this paper
• Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets.

  2025cites this paper
• Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS

  2024cites this paper
• Shear wave elastography to assess stiffness of the human ovary and other reproductive tissues across the reproductive lifespan in health and disease

  2024cites this paper
• Type I fiber decrease and ectopic fat accumulation in skeletal muscle from women with PCOS

  2023cites this paper
• Biomarker Development for Early Diagnosis of PCOS

  2023cites this paper
• Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature

  2023cites this paper
• Transforming growth factor β1 impairs the transcriptomic response to contraction in myotubes from women with polycystic ovary syndrome

  2022cites this paper
• Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

  2022cites this paper
• Key signalling pathways underlying the aetiology of polycystic ovary syndrome.

  2022cites this paper
• The Upregulation of HAS2-AS1 Relates to the Granulosa Cell Dysfunction by Repressing TGF-β Signaling and Upregulating HAS2

  2022cites this paper
• Thyroid Dysfunction: In Connection with PCOS

  2022cites this paper
• High-Fat Diet and Female Fertility across Lifespan: A Comparative Lesson from Mammal Models

  2022cites this paper
• Further delineation of familial polycystic ovary syndrome (PCOS) via whole‐exome sequencing: PCOS‐related rare FBN3 and FN1 gene variants are identified

  2022cites this paper
• DNA Methylation in Polycystic Ovary Syndrome：Emerging Evidence and Challenges.

  2022cites this paper
• Polycystic Ovary Syndrome: the Epigenetics Behind the Disease

  2021cites this paper
• Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis: How Far Is Our Understanding?

  2021cites this paper
• Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling?

  2021cites this paper
• Transforming Growth Factor Beta 1 Alters Glucose Uptake but Not Insulin Signalling in Human Primary Myotubes From Women With and Without Polycystic Ovary Syndrome

  2021cites this paper
• TGF-β1 Increases GDNF Production by Upregulating the Expression of GDNF and Furin in Human Granulosa-Lutein Cells

  2020cites this paper
• Association of IL-1β, IL-6, TNF-α, and TGFβ1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome

  2020cites this paper
• The p38 signaling pathway mediates the TGF‐β1‐induced increase in type I collagen deposition in human granulosa cells

  2020cites this paper
• Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases

  2019cites this paper
• The transcriptional regulator CBX2 and ovarian function: A whole genome and whole transcriptome approach

  2019cites this paper
• Activation of TGF‐β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells

  2018cites this paper
• SNAIL Mediates TGF-&bgr;1–Induced Downregulation of Pentraxin 3 Expression in Human Granulosa Cells

  2018cites this paper
• Ovarian angiogenesis in polycystic ovary syndrome.

  2018cites this paper
• Düşük Doz Kapsaisin Uygulanan Sıçanların Ovaryumlarında TGF-Beta 1’in İmmunohistokimyasal Yerleşimi

  2018cites this paper
• Influence of obesity on soluble endoglin and transforming growth factor β1 in women with polycystic ovary syndrome

  2018cites this paper
• The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome.

  2017cites this paper
• Thyroid disorders in polycystic ovary syndrome.

  2017cites this paper
• FBN3 gene involved in pathogenesis of a Chinese family with Bardet-Biedl syndrome

  2017cites this paper
• Vitamin D and aspects of female fertility

  2017cites this paper
• PAI‐1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF‐β and TNF‐α in mononuclear cells by insulin‐sensitizing drugs

  2017cites this paper
• Transforming growth factor-β 1 increases lysyl oxidase expression by downregulating MIR 29 A in human granulosa lutein cells

  2016cites this paper
• Transforming growth factor-β1 increases lysyl oxidase expression by downregulating MIR29A in human granulosa lutein cells.

  2016cites this paper
• Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women

  2016cites this paper
• Thyroid and polycystic ovary syndrome

  2015cites this paper
• Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome.

  2015cites this paper
• The Emerging Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome

  2015cites this paper
• Fibrillin-containing microfibrils are key signal relay stations for cell function

  2015cites this paper
• Polymorphisms and haplotypes of the TGF-β1 gene are associated with risk of polycystic ovary syndrome in Chinese Han women.

  2015cites this paper
• Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.

  2015cites this paper
• ADAMTS proteases in fertility.

  2015cites this paper
• Study of the association of the T869C polymorphism of the transforming growth factor-β1 gene with polycystic ovary syndrome.

  2015cites this paper
• Mechanisms in endocrinology: thyroid and polycystic ovary syndrome.

  2014cites this paper
• Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation

  2014cites this paper
• Basic research in PCOS: are we reaching new frontiers?

  2014cites this paper
• The Role of TGF-β in Polycystic Ovary Syndrome

  2014influential citation
• Recent Advances in the Genetics of Polycystic Ovary Syndrome

  2014cites this paper
• in Polycystic Ovary Syndrome β The Role of TGF -

  2013influential citation
• Nonhuman primate models of polycystic ovary syndrome.

  2013cites this paper
• Evolutionary Insights into Fibrillin Structure and Function in the Extracellular Matrix

  2013cites this paper
• Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.

  2013cites this paper
• Genetics of the polycystic ovary syndrome.

  2013cites this paper
• Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys

  2011cites this paper
• TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs.

  2011cites this paper
• Study of the association of the T 869 C polymorphism of the transforming growth factor-β 1 gene with polycystic ovary syndrome

  year unknowncites this paper
• Investigation the Relation Between Transforming Growth Factor-β1 Bioavailability with Vitamin D and Calcium in PCOS Patients

  year unknowncites this paper